{"id":57932,"date":"2026-02-25T14:40:57","date_gmt":"2026-02-25T06:40:57","guid":{"rendered":"https:\/\/flcube.com\/?p=57932"},"modified":"2026-02-25T14:41:01","modified_gmt":"2026-02-25T06:41:01","slug":"mgi-tech-sells-complete-genomics-to-swiss-rockets-for-50m-divests-us-unit-to-mitigate-geopolitical-risks","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=57932","title":{"rendered":"MGI Tech Sells Complete Genomics to Swiss Rockets for $50M \u2013 Divests US Unit to Mitigate Geopolitical Risks"},"content":{"rendered":"\n<p><strong>MGI Tech (<a href=\"https:\/\/www.google.com\/finance\/quote\/688114:SHA\">SHA:\u202f688114<\/a>)<\/strong> announced the sale of <strong>100% equity<\/strong> in its <strong>US subsidiary, Complete Genomics (CGI)<\/strong>, to <strong>Swiss life sciences group Swiss Rockets<\/strong> for <strong>USD\u202f50\u202fmillion<\/strong>. The divestiture aims to <strong>avoid geopolitical risks<\/strong> while preserving MGI Tech&#8217;s access to core sequencing technologies in the US market through strategic licensing arrangements.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-transaction-overview\">Transaction Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Seller<\/strong><\/td><td>MGI Tech (SHA:\u202f688114)<\/td><\/tr><tr><td><strong>Buyer<\/strong><\/td><td>Swiss Rockets (Swiss life sciences group)<\/td><\/tr><tr><td><strong>Asset Sold<\/strong><\/td><td>100% equity in Complete Genomics (CGI)<\/td><\/tr><tr><td><strong>Transaction Value<\/strong><\/td><td><strong>USD\u202f50\u202fmillion<\/strong><\/td><\/tr><tr><td><strong>CGI Operations<\/strong><\/td><td>R&amp;D, production, and sales of sequencing equipment and reagents (US market)<\/td><\/tr><tr><td><strong>Post\u2011Closing Status<\/strong><\/td><td>CGI integrated into Swiss Rockets; continues operating as US company<\/td><\/tr><tr><td><strong>Strategic Rationale<\/strong><\/td><td>Mitigate geopolitical risks<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-technology-preservation-framework\">Technology Preservation Framework<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-reverse-licensing-agreement-pre-closing\">Reverse Licensing Agreement (Pre\u2011Closing)<\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Parameter<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Licensor<\/strong><\/td><td>Complete Genomics (CGI)<\/td><\/tr><tr><td><strong>Licensee<\/strong><\/td><td>MGI US LLC (MGI Tech subsidiary)<\/td><\/tr><tr><td><strong>Scope<\/strong><\/td><td>205 patents + technical know\u2011how + trademarks<\/td><\/tr><tr><td><strong>Coverage Areas<\/strong><\/td><td>Library construction, sequencing methods, hardware systems, software algorithms, reagent technologies<\/td><\/tr><tr><td><strong>Terms<\/strong><\/td><td>Permanent, free, irrevocable<\/td><\/tr><tr><td><strong>Strategic Purpose<\/strong><\/td><td>Ensures MGI Tech retains global technology rights, including US market access<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-expanded-exclusive-license-agreement-concurrent\">Expanded Exclusive License Agreement (Concurrent)<\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Parameter<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Licensor<\/strong><\/td><td>MGI Tech<\/td><\/tr><tr><td><strong>Licensee<\/strong><\/td><td>Swiss Rockets<\/td><\/tr><tr><td><strong>Licensed Technology<\/strong><\/td><td>StandardMPS core gene sequencing platform<\/td><\/tr><tr><td><strong>Territory<\/strong><\/td><td><strong>Exclusive rights in US and Canada<\/strong><\/td><\/tr><tr><td><strong>Commercial Implication<\/strong><\/td><td>Swiss Rockets gains regional control; MGI Tech retains underlying IP<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-implications\">Strategic Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Geopolitical Risk Mitigation:<\/strong> The divestiture addresses <strong>US\u2011China technology tensions<\/strong> by removing direct Chinese ownership of a US\u2011based sequencing entity, potentially reducing regulatory scrutiny and export control risks.<\/li>\n\n\n\n<li><strong>Technology Continuity:<\/strong> The <strong>reverse licensing agreement<\/strong> ensures MGI Tech maintains <strong>unfettered access<\/strong> to CGI&#8217;s 205 patents and core technologies globally\u2014preserving R&amp;D capabilities and product development pipelines.<\/li>\n\n\n\n<li><strong>Market Access Preservation:<\/strong> Through the <strong>StandardMPS exclusive license<\/strong>, MGI Tech&#8217;s technology remains available in North America via Swiss Rockets&#8217; commercial infrastructure, avoiding market exit.<\/li>\n\n\n\n<li><strong>Swiss Rockets Expansion:<\/strong> The acquisition provides Swiss Rockets with <strong>established US sequencing operations<\/strong>, manufacturing capacity, and an immediate foothold in the world&#8217;s largest genomics market.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-context\">Market Context<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Factor<\/th><th>Impact<\/th><\/tr><\/thead><tbody><tr><td><strong>US\u2011China Biotech Tensions<\/strong><\/td><td>Increasing scrutiny of Chinese\u2011owned genomics companies; MGI Tech&#8217;s divestiture follows similar moves by other Chinese tech firms<\/td><\/tr><tr><td><strong>Genomics Market Consolidation<\/strong><\/td><td>Swiss Rockets gains operational scale; MGI Tech focuses on non\u2011US markets while retaining technology upside<\/td><\/tr><tr><td><strong>IP Strategy Innovation<\/strong><\/td><td>Reverse licensing model may serve as template for other Chinese biotechs seeking US market access amid geopolitical constraints<\/td><\/tr><tr><td><strong>Sequencing Competition<\/strong><\/td><td>Illumina maintains US dominance; CGI\/Swiss Rockets combination may challenge mid\u2011market segment<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding transaction closing timelines, technology licensing continuity, and market access outcomes. Actual results may differ due to risks including regulatory approval delays, technology transfer challenges, and competitive dynamics in the sequencing market.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>MGI Tech (SHA:\u202f688114) announced the sale of 100% equity in its US subsidiary, Complete Genomics&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[178,1276],"class_list":["post-57932","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-mgi-tech","tag-sha-688114"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>MGI Tech Sells Complete Genomics to Swiss Rockets for $50M \u2013 Divests US Unit to Mitigate Geopolitical Risks - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"MGI Tech (SHA:\u202f688114) announced the sale of 100% equity in its US subsidiary, Complete Genomics (CGI), to Swiss life sciences group Swiss Rockets for USD\u202f50\u202fmillion. The divestiture aims to avoid geopolitical risks while preserving MGI Tech&#039;s access to core sequencing technologies in the US market through strategic licensing arrangements.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=57932\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MGI Tech Sells Complete Genomics to Swiss Rockets for $50M \u2013 Divests US Unit to Mitigate Geopolitical Risks\" \/>\n<meta property=\"og:description\" content=\"MGI Tech (SHA:\u202f688114) announced the sale of 100% equity in its US subsidiary, Complete Genomics (CGI), to Swiss life sciences group Swiss Rockets for USD\u202f50\u202fmillion. The divestiture aims to avoid geopolitical risks while preserving MGI Tech&#039;s access to core sequencing technologies in the US market through strategic licensing arrangements.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=57932\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-25T06:40:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-25T06:41:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57932#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57932\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"MGI Tech Sells Complete Genomics to Swiss Rockets for $50M \u2013 Divests US Unit to Mitigate Geopolitical Risks\",\"datePublished\":\"2026-02-25T06:40:57+00:00\",\"dateModified\":\"2026-02-25T06:41:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57932\"},\"wordCount\":459,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"MGI Tech\",\"SHA: 688114\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=57932#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57932\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=57932\",\"name\":\"MGI Tech Sells Complete Genomics to Swiss Rockets for $50M \u2013 Divests US Unit to Mitigate Geopolitical Risks - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-02-25T06:40:57+00:00\",\"dateModified\":\"2026-02-25T06:41:01+00:00\",\"description\":\"MGI Tech (SHA:\u202f688114) announced the sale of 100% equity in its US subsidiary, Complete Genomics (CGI), to Swiss life sciences group Swiss Rockets for USD\u202f50\u202fmillion. The divestiture aims to avoid geopolitical risks while preserving MGI Tech's access to core sequencing technologies in the US market through strategic licensing arrangements.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57932#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=57932\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57932#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MGI Tech Sells Complete Genomics to Swiss Rockets for $50M \u2013 Divests US Unit to Mitigate Geopolitical Risks\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MGI Tech Sells Complete Genomics to Swiss Rockets for $50M \u2013 Divests US Unit to Mitigate Geopolitical Risks - Insight, China&#039;s Pharmaceutical Industry","description":"MGI Tech (SHA:\u202f688114) announced the sale of 100% equity in its US subsidiary, Complete Genomics (CGI), to Swiss life sciences group Swiss Rockets for USD\u202f50\u202fmillion. The divestiture aims to avoid geopolitical risks while preserving MGI Tech's access to core sequencing technologies in the US market through strategic licensing arrangements.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=57932","og_locale":"en_US","og_type":"article","og_title":"MGI Tech Sells Complete Genomics to Swiss Rockets for $50M \u2013 Divests US Unit to Mitigate Geopolitical Risks","og_description":"MGI Tech (SHA:\u202f688114) announced the sale of 100% equity in its US subsidiary, Complete Genomics (CGI), to Swiss life sciences group Swiss Rockets for USD\u202f50\u202fmillion. The divestiture aims to avoid geopolitical risks while preserving MGI Tech's access to core sequencing technologies in the US market through strategic licensing arrangements.","og_url":"https:\/\/flcube.com\/?p=57932","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-02-25T06:40:57+00:00","article_modified_time":"2026-02-25T06:41:01+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=57932#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=57932"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"MGI Tech Sells Complete Genomics to Swiss Rockets for $50M \u2013 Divests US Unit to Mitigate Geopolitical Risks","datePublished":"2026-02-25T06:40:57+00:00","dateModified":"2026-02-25T06:41:01+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=57932"},"wordCount":459,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["MGI Tech","SHA: 688114"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=57932#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=57932","url":"https:\/\/flcube.com\/?p=57932","name":"MGI Tech Sells Complete Genomics to Swiss Rockets for $50M \u2013 Divests US Unit to Mitigate Geopolitical Risks - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-02-25T06:40:57+00:00","dateModified":"2026-02-25T06:41:01+00:00","description":"MGI Tech (SHA:\u202f688114) announced the sale of 100% equity in its US subsidiary, Complete Genomics (CGI), to Swiss life sciences group Swiss Rockets for USD\u202f50\u202fmillion. The divestiture aims to avoid geopolitical risks while preserving MGI Tech's access to core sequencing technologies in the US market through strategic licensing arrangements.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=57932#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=57932"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=57932#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"MGI Tech Sells Complete Genomics to Swiss Rockets for $50M \u2013 Divests US Unit to Mitigate Geopolitical Risks"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/57932","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=57932"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/57932\/revisions"}],"predecessor-version":[{"id":57933,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/57932\/revisions\/57933"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=57932"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=57932"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=57932"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}